首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.
【24h】

Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.

机译:巴雷特食管相关的高度不典型增生在激光捕获显微解剖档案组织中的表达分析。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Identifying genes differentially expressed in nondysplastic BE (NDBE) from those expressed in high-grade dysplasia (HGD) should be of value in improving our understanding of this transition and may yield new diagnostic and/or prognostic markers. The aim of this study was to determine the differential transcriptome of HGD compared with NDBE through gene microarray analysis of epithelial cells microdissected from archival tissue specimens. EXPERIMENTAL DESIGN: Laser capture microdissection was used to isolate epithelial cells from adjacent inflammatory and stromal cells. Epithelial mRNA was extracted from areas of NDBE and HGD in matched biopsies from 11 patients. mRNA was reverse transcribed and applied on Affymetrix cDNA microarray chips customized for formalin-exposed tissue. For a subset of these genes, differential gene expression was confirmed by real-time PCR and immunohistochemistry. RESULTS: There were 131 genes overexpressed by at least 2.5-fold in HGD versus NDBE and 16 genes that were underexpressed by at least 2.5-fold. Among the overexpressed genes are several previously shown to be increased in the neoplastic progression of BE, as well as novel genes such as lipocalin-2, S100A9, matrix metallopeptidase 12, secernin 1, and topoisomerase IIalpha. Genes decreased in dysplastic epithelium include MUC5AC, trefoil factor 1 (TFF1), meprin A, and CD13. Real-time PCR validated the changes in expression in 24 of 28 selected genes. Immunohistochemistry confirmed increased protein expression for topoisomerase IIalpha, S100A9, and lipocalin-2 and decreased expression of TFF1 across the spectrum of BE-associated dysplasia from NDBE through adenocarcinoma. CONCLUSIONS: This is the first study to identify epithelial genes differentially expressed in HGD versus NDBE in matched patient samples. The genes identified include several previously implicated in the pathogenesis of BE-associated dysplasia and new candidates for further investigation.
机译:目的:鉴定在非典型增生(HGD)中非典型增生(NDBE)中差异表达的基因,对于提高我们对这一转变的理解具有价值,并可能产生新的诊断和/或预后指标。这项研究的目的是通过基因芯片分析从档案组织标本中显微切割的上皮细胞,确定HGD与NDBE相比的差异转录组。实验设计:激光捕获显微切割用于从邻近的炎性和基质细胞中分离上皮细胞。上皮mRNA提取自11例患者的匹配活检中的NDBE和HGD区域。将mRNA逆转录并应用于为福尔马林暴露的组织定制的Affymetrix cDNA微阵列芯片上。对于这些基因的一个子集,通过实时PCR和免疫组织化学证实了差异基因的表达。结果:HGD与NDBE相比,有131个基因高表达至少2.5倍,而与NDBE相比,有16个基因低表达至少2.5倍。在过表达的基因中,有几个先前被证明在BE的肿瘤进展中增加,以及新的基因,例如lipocalin-2,S100A9,基质金属肽酶12,secernin 1和拓扑异构酶IIalpha。增生异常上皮减少的基因包括MUC5AC,三叶因子1(TFF1),meprin A和CD13。实时PCR验证了28个选定基因中24个基因的表达变化。免疫组织化学证实拓扑异构酶IIalpha,S100A9和lipocalin-2的蛋白质表达增加,而从NDBE到腺癌的BE相关增生谱中TFF1的表达减少。结论:这是鉴定匹配的患者样品中以HGD与NDBE差异表达的上皮基因的第一项研究。鉴定出的基因包括先前与BE相关的发育异常的发病机制有关的几个基因,以及进一步研究的新候选基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号